Abstract
Lung cancer patients frequently present with to bone metastases. Such lesions are responsible for increased morbidity, low quality of life, and increased costs to patients and the health care system. Pain is the most common symptom; however, these lesions also present as skeletal related events (SRE) which include pathological fractures, hypercalcemia, spinal cord and nerve compressions and cause the need for surgery and/or radiotherapy. Even though bone metastases are associated with poor prognosis, current treatment multimodalities continue to improve survival. Awareness and effective treatment of these lesions is paramount to maintain a good quality of life and function in lung cancer patients.
Reference46 articles.
1. Lung Cancer Statistics: How Common is Lung Cancer. (n.d.). Retrieved January 17, 2021, from https://www.cancer.org/cancer/lung-cancer/about/key-statistics.html
2. D’Addario G, Fruh M, Reck M, et al. Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010; 21Suppl 5v116–v119.
3. Stinchcombe TE, Lee CB, Socinski MA. Current approaches to advanced-stage non-small-cell lung cancer: first-line therapy in patients with a good functional status. Clin Lung Cancer 2006; 7Suppl 4S111–S117.
4. Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res, 2006; 12: 6243s–49s.
5. Wang CY, Zhang XY. [(99m)Tc-MDP whole body bone imaging in evaluation of the characteristics of bone metastasis of primary lung cancer]. Zhonghua Zhong Liu Za Zhi, 2010; 32: 382-86.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献